NewslettersNeural Cell News Implementation of a Combined CDK Inhibition and Arginine-Deprivation Approach To Target Arginine-Auxotrophic Glioblastoma Multiforme Cells By Bob - June 22, 2022 0 222 Three arginine-auxotrophic patient-derived Glioblastoma multiforme (GBM) lines with different molecular characteristics were cultured in 2D and 3D and effects of this combined SpyADI/CDKi approach were analyzed in-depth. [Cell Death & Disease] Full Article